top of page
  • Bethany Valente

In The News: "Making the Most of the Rising Biopharma M&A"

Dr. Valente, our Managing Partner and Co-Founder, contributed to the conversation with Pharmaceutial Executive ( about how to overcome common roadblocks to global expansion in Pharma and Biotech.

"Last year was a down year for mergers and acquisitions (M&As) because of the pandemic, but biopharma deal-making is once again on the rise, evidenced by Gilead Sciences finalizing its purchase of Immunomedics. Gilead is one of many global biopharmaceutical companies hoping to find footing in the United States for two reasons: Biotech innovation has skyrocketed and U.S. tax penalties have been mitigated."

To learn more, read the article at:

17 views0 comments

Recent Posts

See All

Let's Get Inspired. Together.

“The Sweetest Boat This Side of Heaven” Owner: Guy Lombardo Builder: Les Staudcher Driver: Danny Foster Tempo VII won 6 first place races, and Guy Lombardo and the Royal Canadians sold hundreds of mil


Commenting has been turned off.
Post: Blog2 Post
bottom of page